RCUS
Arcus Biosciences, Inc. · Healthcare
Gilead Sciences, Inc. bought $320.0M of Arcus Biosciences, Inc.
10% owner
Bought$319,999,995
$21.00Price
15,238,095Shares
+103%Stake
What RCUS did for a copier
- $1,000 copied at Thu, Feb 1 open, $15.92
- $1,192
- S&P 500, same days
- +5.5%
Measured over 30 trading days, to the Mar 15 close.
Gilead Sciences, Inc.'s record
6 other buys with 3 months of prices since 2023: on average −33.8% against the S&P 500, and 0 of 6 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Mon, Jan 29. Filed Wed, Jan 31, 5:00 PM ET, after the close. Returns use the Feb 1 open and the Mar 15 close. Not investment advice.